Table 1 Frequency of HBV serological and molecular markers in the 4 different studied subgroups.
Group | n | Anti-HBc +ve | HBsAg +ve | Anti-HBs +ve | PCR core +ve | PCR surface +ve |
|---|---|---|---|---|---|---|
Haemodialysis Patients (HP) | 813 | 262 (23.2%) | 81 (10.0%) | 126 (15.4%) | 62 (7.6%) | 49 (6.0%) |
HP Controls | 620* | 150 (24.2%) | 24 (3.8%) | 89 (14.3%) | 15 (2.4%) | 8 (1.3%) |
Health care Workers (HCW) | 149 | 30 (20.1%) | 4 (2.7%) | 20 (13.4%) | 4 (2.7%) | 4 (2.7%) |
HCW Controls | 149 | 21 (14.1%) | 4 (2.7%) | 11 (7.4%) | 3 (2.0%) | 2 (1.3%) |